Stay updated on CTX001 in Severe Sickle Cell: Clinical Trial
Sign up to get notified when there's something new on the CTX001 in Severe Sickle Cell: Clinical Trial page.

Latest updates to the CTX001 in Severe Sickle Cell: Clinical Trial page
- Check4 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check11 days agoChange DetectedA site-wide NIH notice announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check18 days agoChange DetectedThe site revision identifier in the page footer changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check25 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 Forbidden page; no study-record content is displayed.SummaryDifference0.2%

- Check46 days agoChange DetectedThe study record page now shows a 403 Forbidden error with a minimal header, replacing the detailed study information and metadata that used to be visible. The page content is currently inaccessible through the provided URL.SummaryDifference18%

- Check67 days agoChange DetectedThe page now shows Revision: v3.6.6 in the footer, replacing the previous v3.6.5. This denotes a small behind-the-scenes update to the site rather than a change to the study details.SummaryDifference0.0%

Stay in the know with updates to CTX001 in Severe Sickle Cell: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX001 in Severe Sickle Cell: Clinical Trial page.